Загрузка...
JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis
We analyzed reports on safety and efficacy of JAK-inhibitors in patients with coronavirus infectious disease-2019 (COVID-19) published between January 1st and March 6th 2021 using the Newcastle-Ottawa and Jadad scales for quality assessment. We used disease severity as a proxy for time when JAK-inhi...
Сохранить в:
| Опубликовано в: : | Leukemia |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group UK
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8119232/ https://ncbi.nlm.nih.gov/pubmed/33990684 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41375-021-01266-6 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|